Curocell Inc. (KOSDAQ:372320)
South Korea flag South Korea · Delayed Price · Currency is KRW
31,550
-500 (-1.56%)
Last updated: Jun 27, 2025

Curocell Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023
Period Ending
Mar '25 Dec '24 Dec '23
Cash & Equivalents
4,3504,5819,917
Short-Term Investments
32,4747,20032,000
Cash & Short-Term Investments
36,82511,78141,917
Cash Growth
--71.90%-
Other Receivables
11.358.85608.84
Receivables
11.358.85608.84
Prepaid Expenses
546746.64109.74
Other Current Assets
439.78511.2151.17
Total Current Assets
37,82213,04742,787
Property, Plant & Equipment
54,00655,45061,242
Long-Term Investments
1,6961,500-
Other Intangible Assets
3,2321,471520.99
Other Long-Term Assets
3,473263.17419.75
Total Assets
100,51972,021104,969
Accrued Expenses
207.21330.32254.7
Short-Term Debt
800800800
Current Portion of Long-Term Debt
34,39034,390-
Current Portion of Leases
457.24494.11502.31
Current Income Taxes Payable
1.171.18-
Other Current Liabilities
1,2812,7361,713
Total Current Liabilities
37,13738,7513,270
Long-Term Debt
25,954-39,595
Long-Term Leases
1,5201,6162,020
Other Long-Term Liabilities
11,092662.92552.97
Total Liabilities
77,75742,56745,870
Common Stock
7,1007,1006,806
Additional Paid-In Capital
215,016215,016205,660
Retained Earnings
-206,158-199,095-160,463
Comprehensive Income & Other
6,8046,4347,097
Shareholders' Equity
22,76129,45459,100
Total Liabilities & Equity
100,51972,021104,969
Total Debt
63,12137,30042,918
Net Cash (Debt)
-26,297-25,519-1,000
Net Cash Per Share
-1862.11-1826.04-84.54
Filing Date Shares Outstanding
14.214.213.61
Total Common Shares Outstanding
14.214.213.61
Working Capital
685.09-25,70439,516
Book Value Per Share
1602.982074.344341.49
Tangible Book Value
19,52927,98358,579
Tangible Book Value Per Share
1375.371970.754303.22
Land
5,6995,6995,699
Buildings
23,31323,31023,423
Machinery
15,92715,87915,429
Construction In Progress
47.63-13.95
Updated Mar 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.